AstraZeneca's COVID drug Evusheld unlikely to neutralize newest variant, FDA says

México Noticias Noticias

AstraZeneca's COVID drug Evusheld unlikely to neutralize newest variant, FDA says
México Últimas Noticias,México Titulares
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

The Food and Drug Administration late Friday said that AstraZeneca Plc's undefined COVID-19 drug Evusheld may not provide protection against developing the...

The Food and Drug Administration late Friday said that AstraZeneca Plc's COVID-19 drug Evusheld may not provide protection against developing the illness in people exposed to XBB.1.5, one of the newest COVID subvariants. That's because XBB.1.5 is similar to other subvariants not neutralized by Evusheld, the FDA said."However, we are awaiting additional data to verify that Evusheld is not active against XBB.1.5.

The Food and Drug Administration late Friday said that AstraZeneca Plc's AZN COVID-19 drug Evusheld may not provide protection against developing the illness in people exposed to XBB.1.5, one of the newest COVID subvariants. That's because XBB.1.5 is similar to other subvariants not neutralized by Evusheld, the FDA said."However, we are awaiting additional data to verify that Evusheld is not active against XBB.1.5.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

MarketWatch /  🏆 3. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA grants accelerated approval to Alzheimer's drug for people with early stage diseaseFDA grants accelerated approval to Alzheimer's drug for people with early stage diseaseBREAKING: FDA grants accelerated approval to new Alzheimer's treatment that can slow cognitive decline in people with early stages of the disease.
Leer más »

FDA grants fast-track approval to experimental Alzheimer's drugFDA grants fast-track approval to experimental Alzheimer's drugThe FDA approved lecanemab, which has shown to slow the progression of Alzheimer's disease.
Leer más »

FDA Rules That Retail Pharmacies Can Offer Abortion MedicationFDA Rules That Retail Pharmacies Can Offer Abortion MedicationAbortion bans or restrictions will likely make it illegal to implement the new FDA rule in about half the states.
Leer más »

The FDA Will Now Allow Abortion Pills to be Sold at Retail PharmaciesThe FDA Will Now Allow Abortion Pills to be Sold at Retail PharmaciesPreviously, the first in the two-pill cycle used in medication abortions—mifepristone—had to be accessed via specific doctors and/or mail-order pharmacies.
Leer más »

The FDA Will Now Allow You To Buy Abortion Pills At Normal PharmaciesThe FDA Will Now Allow You To Buy Abortion Pills At Normal PharmaciesThe FDA has changed its rules to make it easier for patients to access abortion pills, which until now were difficult to get.
Leer más »



Render Time: 2025-02-28 23:14:17